U.S. Markets open in 7 hrs 14 mins

Halozyme Therapeutics (HALO) Looks Good: Stock Adds 5.4% in Session

Zacks Equity Research

Halozyme Therapeutics, Inc. HALO was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $14.93 to $17.06 in the past one-month time frame.

The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Halozyme Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Halozyme Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.  

Halozyme Therapeutics, Inc. Price

Halozyme Therapeutics, Inc. Price

Halozyme Therapeutics, Inc. price | Halozyme Therapeutics, Inc. Quote

Investors interested in the Medical – Biomedical and Genetics industry may consider Anika Therapeutics, Inc. ANIK, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is HALO going up? Or down? Predict to see what others think:Up or Down

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
 
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Anika Therapeutics Inc. (ANIK) : Free Stock Analysis Report
 
Halozyme Therapeutics, Inc. (HALO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.